All lobbying filings
LMH Strategic Solutions
LMH Strategic Solutions filed a Q1 report for Stealth Biotherapeutics Inc. on April 18, 2025, reporting $10,000 in lobbying income.
Lobbying for Stealth Biotherapeutics Inc. · Biotechnology company.
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Income
$10,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
2
Lobbying activity
1
FDA process issues. H.R.1262/S.932 - Give Kids a Chance Act of 2025.